What is he best known for?
The fields of study he is best known for:
The scientist’s investigation covers issues in Biochemistry, Antibody, Molecular biology, Extracellular and Monoclonal antibody.
His work on Phosphodiesterase, Alkaline phosphatase, Osteoblast and Hypophosphatasia as part of general Biochemistry research is frequently linked to Lysophosphatidylcholine, bridging the gap between disciplines.
His Antibody research incorporates themes from Receptor, Transferrin and Antigen.
His Molecular biology research incorporates elements of H-2 Antigens, Major histocompatibility complex, Protein G and Binding site.
His Extracellular research integrates issues from Pathologic calcification, Osteopontin and Cellular differentiation.
James W. Goding has researched Monoclonal antibody in several fields, including Transferrin receptor, Agarose, Proteolysis and Virology.
His most cited work include:
- Monoclonal Antibodies: Principles and Practice (1656 citations)
- Use of staphylococcal protein A as an immunological reagent (831 citations)
- Properties of Monoclonal Antibodies to Mouse Ig Allotypes, H-2, and Ia Antigens (788 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Molecular biology, Biochemistry, Antibody, Antigen and Monoclonal antibody.
His Molecular biology research is multidisciplinary, incorporating elements of Complementary DNA, Allotype, Molecular cloning, Gene and Membrane protein.
His Biochemistry study frequently links to other fields, such as Cell biology.
His research brings together the fields of Virology and Antibody.
The various areas that he examines in his Antigen study include Clone, Structural gene and Locus.
His studies deal with areas such as Plasma cell, Transferrin, Proteolysis, Epitope and Polyclonal antibodies as well as Monoclonal antibody.
He most often published in these fields:
- Molecular biology (40.59%)
- Biochemistry (37.62%)
- Antibody (23.76%)
What were the highlights of his more recent work (between 1999-2014)?
- Biochemistry (37.62%)
- Phosphodiesterase (13.86%)
- Molecular biology (40.59%)
In recent papers he was focusing on the following fields of study:
James W. Goding mainly investigates Biochemistry, Phosphodiesterase, Molecular biology, Extracellular and Cell biology.
His biological study deals with issues like Calcium, which deal with fields such as Annexin.
His Molecular biology research is multidisciplinary, incorporating elements of Plasma cell, Nucleic acid, Monoclonal antibody and Calcification.
His research integrates issues of Extracellular matrix, Knockout mouse, Isozyme and Osteopontin in his study of Extracellular.
His studies deal with areas such as Transfection and Transmembrane domain as well as Cell biology.
His Antibody study frequently draws connections to other fields, such as Antigen.
Between 1999 and 2014, his most popular works were:
- Monoclonal Antibodies: Principles and Practice (1656 citations)
- Tissue-nonspecific alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antagonistic regulators of bone mineralization (679 citations)
- Physiological and pathophysiological functions of the ecto-nucleotide pyrophosphatase/phosphodiesterase family (308 citations)
In his most recent research, the most cited papers focused on:
James W. Goding focuses on Biochemistry, Phosphodiesterase, Extracellular, Hypophosphatasia and Osteoblast.
James W. Goding has researched Phosphodiesterase in several fields, including Sphingosine, Pyrophosphatase and Lipid signaling.
His Extracellular research is classified as research in Cell biology.
As a part of the same scientific family, James W. Goding mostly works in the field of Hypophosphatasia, focusing on Calcium metabolism and, on occasion, Molecular biology.
While working in this field, he studies both Molecular biology and Calcification inhibitor.
The study incorporates disciplines such as Calcium and In vivo in addition to Osteoblast.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
